Patient advocate slams cancer agency report over 'wall of silence' on PHARMAC funding


2 February 2021 - The Cancer Control Agency has released its first report into cancer in New Zealand, but one patient advocate says it doesn't properly address the "wall of silence" around PHARMAC's drug funding.

Malcolm Mulholland, who chairs Patient Voice Aotearoa, told Breakfast this morning that there were pros and cons in He Pūrongo Mate Pukupuku o Aotearoa 2020, The State of Cancer in New Zealand 2020.

"I think the cons for us is that it only dedicates one page in a 152 page report to that of PHARMAC and the funding of cancer drugs, and that's an area that we deal with on a daily basis," Mulholland said.

Read TVNZ article

Michael Wonder

Posted by:

Michael Wonder